{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T03:52:55Z","timestamp":1789271575715,"version":"build-2803163510"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:00:00Z","timestamp":1664409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["K24-AR-063120"],"award-info":[{"award-number":["K24-AR-063120"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["1R01-AR070470-01A1"],"award-info":[{"award-number":["1R01-AR070470-01A1"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"NIAMS","doi-asserted-by":"publisher","award":["AR007080"],"award-info":[{"award-number":["AR007080"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To establish a framework by which experts define disease subsets in systemic sclerosis associated interstitial lung disease (SSc-ILD).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A conceptual framework for subclinical, clinical and progressive ILD was provided to 83 experts, asking them to use the framework and classify actual SSc-ILD patients. Each patient profile was designed to be classified by at least four experts in terms of severity and risk of progression at baseline; progression was based on 1-year follow-up data. A consensus was reached if \u226575% of experts agreed. Experts provided information on which items were important in determining classification.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Forty-four experts (53%) completed the survey. Consensus was achieved on the dimensions of severity (75%, 60 of 80 profiles), risk of progression (71%, 57 of 80 profiles) and progressive ILD (60%, 24 of 40 profiles). For profiles achieving consensus, most were classified as clinical ILD (92%), low risk (54%) and stable (71%). Severity and disease progression overlapped in terms of framework items that were most influential in classifying patients (forced vital capacity, extent of lung involvement on high resolution chest CT [HRCT]); risk of progression was influenced primarily by disease duration.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Using our proposed conceptual framework, international experts were able to achieve a consensus on classifying SSc-ILD patients along the dimensions of disease severity, risk of progression and progression over time. Experts rely on similar items when classifying disease severity and progression: a combination of spirometry and gas exchange and quantitative HRCT.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keac557","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T14:00:01Z","timestamp":1664460001000},"page":"1877-1886","source":"Crossref","is-referenced-by-count":15,"title":["Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease"],"prefix":"10.1093","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9750-5771","authenticated-orcid":false,"given":"David","family":"Roofeh","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology, Scleroderma Program, University of Michigan , Ann Arbor, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin K","family":"Brown","sequence":"additional","affiliation":[{"name":"Department of Medicine, National Jewish Health , Denver, CO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5859-8744","authenticated-orcid":false,"given":"Ella A","family":"Kazerooni","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology, Scleroderma Program, University of Michigan , Ann Arbor, MI, USA"},{"name":"Department of Radiology, Division of Cardiothoracic Radiology, University of Michigan , Ann Arbor, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5607-4872","authenticated-orcid":false,"given":"Donald","family":"Tashkin","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Pulmonary and Critical Care Medicine, David Geffen School of Medicine at UCLA , Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8059-9978","authenticated-orcid":false,"given":"Shervin","family":"Assassi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology, McGovern Medical School, University of Texas Health Science Center at Houston , Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2412-3182","authenticated-orcid":false,"given":"Fernando","family":"Martinez","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Pulmonary Critical Care Medicine, Weill Cornell School of Medicine , New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2108-6248","authenticated-orcid":false,"given":"Athol U","family":"Wells","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Pulmonology, Royal Brompton Hospital and National Heart and Lung Institute , London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7506-6643","authenticated-orcid":false,"given":"Ganesh","family":"Raghu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Pulmonology, Critical Care and Sleep Medicine, University of Washington School of Medicine , Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3975-8938","authenticated-orcid":false,"given":"Christopher P","family":"Denton","sequence":"additional","affiliation":[{"name":"Centre for Rheumatology, Division of Medicine, University College London , London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0072-6939","authenticated-orcid":false,"given":"Lorinda","family":"Chung","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Immunology and Rheumatology, Stanford University, and Palo Alto VA Health Care System , Palo Alto, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6467-7422","authenticated-orcid":false,"given":"Anna-Maria","family":"Hoffmann-Vold","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Oslo University Hospital , Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0546-8310","authenticated-orcid":false,"given":"Oliver","family":"Distler","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, University Hospital Zurich, University of Zurich , Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1205-5511","authenticated-orcid":false,"given":"Kerri A","family":"Johannson","sequence":"additional","affiliation":[{"name":"Departments of Medicine and Community Health Sciences, Section of Respiratory Medicine, University of Calgary , Calgary, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6149-0002","authenticated-orcid":false,"given":"Yannick","family":"Allanore","sequence":"additional","affiliation":[{"name":"Department of Rheumatology A, Cochin Hospital, APHP, Universit\u00e9 de Paris , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9866-0124","authenticated-orcid":false,"given":"Eric L","family":"Matteson","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology, Mayo Clinic , Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0784-1331","authenticated-orcid":false,"given":"Leticia","family":"Kawano-Dourado","sequence":"additional","affiliation":[{"name":"HCor Research Institute, Hospital do Cora\u00e7\u00e3o , S\u00e3o Paulo, Brazil"},{"name":"Pulmonary Division, Heart Institute (InCor), University of Sao Paulo Medical School , S\u00e3o Paulo, Brazil"},{"name":"INSERM 1152, University of Paris , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2793-2364","authenticated-orcid":false,"given":"John D","family":"Pauling","sequence":"additional","affiliation":[{"name":"Musculoskeletal Research Unit, Bristol Medical School, University of Bristol , Bristol, UK"},{"name":"Department of Rheumatology, North Bristol NHS Trust , Southmead, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5187-3141","authenticated-orcid":false,"given":"James R","family":"Seibold","sequence":"additional","affiliation":[{"name":"Scleroderma Research Consultants , Aiken, SC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3750-6569","authenticated-orcid":false,"given":"Elizabeth R","family":"Volkmann","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology, David Geffen School of Medicine at UCLA , Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon L F","family":"Walsh","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute, Imperial College London , London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9529-3111","authenticated-orcid":false,"given":"Chester V","family":"Oddis","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine , Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4060-8443","authenticated-orcid":false,"given":"Eric S","family":"White","sequence":"additional","affiliation":[{"name":"Boehringer Ingelheim Pharmaceuticals, Inc. , Ridgefield, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3067-7349","authenticated-orcid":false,"given":"Shaney L","family":"Barratt","sequence":"additional","affiliation":[{"name":"Academic Respiratory Unit, School of Clinical Sciences, University of Bristol , Bristol, UK"},{"name":"Bristol Interstitial Lung Disease Service, North Bristol NHS Trust , Southmead, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5560-6390","authenticated-orcid":false,"given":"Elana J","family":"Bernstein","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology, Columbia University School of Medicine, Vagelos College of Physicians and Surgeons , New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2765-0922","authenticated-orcid":false,"given":"Robyn T","family":"Domsic","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine , Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0237-739X","authenticated-orcid":false,"given":"Paul F","family":"Dellaripa","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Harvard Medical School , Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2538-3362","authenticated-orcid":false,"given":"Richard","family":"Conway","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology, Trinity College Dublin, University of Dublin , Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4622-618X","authenticated-orcid":false,"given":"Ivan","family":"Rosas","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Pulmonology, Critical Care and Sleep Medicine, Baylor College of Medicine , Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Bhatt","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, The Ohio State University Wexner Medical Center , Columbus, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9588-347X","authenticated-orcid":false,"given":"Vivien","family":"Hsu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology, Rutgers-Robert Wood Johnson Medical School , New Brunswick, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6727-1273","authenticated-orcid":false,"given":"Francesca","family":"Ingegnoli","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences and Community Health, Research Center for Adult and Pediatric Rheumatic Diseases, Universit\u00e0 degli Studi di Milano , Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4666-0250","authenticated-orcid":false,"given":"Bashar","family":"Kahaleh","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology, University of Toledo Medical Center , Toledo, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1099-6967","authenticated-orcid":false,"given":"Puneet","family":"Garcha","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Pulmonology, Critical Care and Sleep Medicine, Baylor College of Medicine , Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9112-1315","authenticated-orcid":false,"given":"Nishant","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, University of Cincinnati , Cincinnati, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surabhi","family":"Khanna","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology, University of Cincinnati , Cincinnati, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6065-5680","authenticated-orcid":false,"given":"Peter","family":"Korsten","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Rheumatology, University Medical Center G\u00f6ttingen , G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia","family":"Lin","sequence":"additional","affiliation":[{"name":"Genentech, Inc , San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C","family":"Mathai","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Pulmonology, Critical Care and Sleep Medicine, Johns Hopkins University School of Medicine , Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4978-4072","authenticated-orcid":false,"given":"Vibeke","family":"Strand","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Immunology and Rheumatology, Stanford University , Palo Alto, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy J","family":"Doyle","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School , Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6333-0133","authenticated-orcid":false,"given":"Virginia","family":"Steen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology, Georgetown University School of Medicine , Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald F","family":"Zoz","sequence":"additional","affiliation":[{"name":"Boehringer Ingelheim Pharmaceuticals, Inc. , Ridgefield, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6300-5341","authenticated-orcid":false,"given":"Juan","family":"Ovalles-Bonilla","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Hospital General Universitario Gregorio Mara\u00f1\u00f3n , Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6193-6396","authenticated-orcid":false,"given":"Ignasi","family":"Rodriguez-Pinto","sequence":"additional","affiliation":[{"name":"Autoimmune Disease Unit. Deaprtment of Internal Medicine. Hospital Mutua de Terrassa, University of Barcelona , Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7666-1361","authenticated-orcid":false,"given":"Padmanabha D","family":"Shenoy","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Center for Arthritis and Rheumatism Excellence , Kochi, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Lewandoski","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology, University of Michigan-Metro Health , Grand Rapids, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Belloli","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan , Ann Arbor, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5289-3312","authenticated-orcid":false,"given":"Alain","family":"Lescoat","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology, Scleroderma Program, University of Michigan , Ann Arbor, MI, USA"},{"name":"Department of Internal Medicine and Clinical Immunology, Rennes University Hospital , Rennes, France"},{"name":"Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de Recherche en Sant\u00e9, Environnement et Travail) - UMR_S 1085 , Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6134-3387","authenticated-orcid":false,"given":"Vivek","family":"Nagaraja","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology, Scleroderma Program, University of Michigan , Ann Arbor, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, School of Public Health, University of Michigan , Ann Arbor, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suiyuan","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, School of Public Health, University of Michigan , Ann Arbor, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7192-9149","authenticated-orcid":false,"given":"Toby","family":"Maher","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, University of Southern California , Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1412-4453","authenticated-orcid":false,"given":"Dinesh","family":"Khanna","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology, Scleroderma Program, University of Michigan , Ann Arbor, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,9,29]]},"reference":[{"key":"2023050208160020300_keac557-B1","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"key":"2023050208160020300_keac557-B2","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/BOR.0000000000000551","article-title":"Mortality and survival in systemic sclerosis","volume":"30","author":"Poudel","year":"2018","journal-title":"Curr Opin Rheumatol"},{"key":"2023050208160020300_keac557-B3","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.semarthrit.2014.05.010","article-title":"Mortality and survival in systemic sclerosis: systematic review and meta-analysis","volume":"44","author":"Rubio-Rivas","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"2023050208160020300_keac557-B4","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1007\/s12325-019-00929-2","article-title":"Economic burden of illness among commercially insured patients with systemic sclerosis with interstitial lung disease in the USA: a Claims Data Analysis","volume":"36","author":"Zhou","year":"2019","journal-title":"Adv Ther"},{"issue":"Suppl 131","key":"2023050208160020300_keac557-B5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.55563\/clinexprheumatol\/9ivp9g","article-title":"Hospitalisations related to systemic sclerosis and the impact of interstitial lung disease. Analysis of patients hospitalised at the University of Michigan, USA","volume":"39","author":"Sankar","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"2023050208160020300_keac557-B6","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database","volume":"69","author":"Tyndall","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2023050208160020300_keac557-B7","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1136\/annrheumdis-2017-211448","article-title":"Mapping and predicting mortality from systemic sclerosis","volume":"76","author":"Elhai","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2023050208160020300_keac557-B8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2147\/CLEP.S191418","article-title":"Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease","volume":"11","author":"Bergamasco","year":"2019","journal-title":"Clin Epidemiol"},{"key":"2023050208160020300_keac557-B9","doi-asserted-by":"crossref","first-page":"e329","DOI":"10.1016\/j.lpm.2014.08.002","article-title":"Interstitial lung disease in systemic sclerosis","volume":"43","author":"Wells","year":"2014","journal-title":"Press Medicale"},{"key":"2023050208160020300_keac557-B10","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1055\/s-0039-1683431","article-title":"Systemic sclerosis associated interstitial lung disease: a comprehensive overview","volume":"40","author":"Mackintosh","year":"2019","journal-title":"Semin Respir Crit Care Med"},{"key":"2023050208160020300_keac557-B11","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/BOR.0000000000000711","article-title":"Management of systemic sclerosis: the first five years","volume":"32","author":"Roofeh","year":"2020","journal-title":"Curr Opin Rheumatol"},{"key":"2023050208160020300_keac557-B12","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa1903076","article-title":"Nintedanib for systemic sclerosis-associated interstitial lung disease","volume":"380","author":"Distler","year":"2019","journal-title":"N Engl J Med"},{"key":"2023050208160020300_keac557-B13","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S2213-2600(20)30318-0","article-title":"Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"8","author":"Khanna","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2023050208160020300_keac557-B14","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.3899\/jrheum.141182","article-title":"Connective tissue disease-associated interstitial lung diseases (CTD-ILD)\u2014report from OMERACT CTD-ILD working group","volume":"42","author":"Khanna","year":"2015","journal-title":"J Rheumatol"},{"key":"2023050208160020300_keac557-B15","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/BOR.0000000000000592","article-title":"Management of systemic sclerosis-associated interstitial lung disease","volume":"31","author":"Roofeh","year":"2019","journal-title":"Curr Opin Rheumatol"},{"key":"2023050208160020300_keac557-B16","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.rdc.2015.04.006","article-title":"Management of systemic sclerosis-associated interstitial lung disease (SSc-ILD)","volume":"41","author":"Culp Silver","year":"2015","journal-title":"Rheum Dis Clin N Am"},{"key":"2023050208160020300_keac557-B17","first-page":"22","volume-title":"American College Of Rheumatology Study Group: interstitial lung disease and rheumatic diseases","author":"Roofeh","year":"2018"},{"key":"2023050208160020300_keac557-B18","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S2213-2600(16)30152-7","article-title":"Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial","volume":"4","author":"Tashkin","year":"2016","journal-title":"Lancet Respir Med"},{"key":"2023050208160020300_keac557-B19","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/art.39501","article-title":"The American College of Rheumatology provisional composite response index for clinical trials in early diffuse cutaneous systemic sclerosis","volume":"68","author":"Khanna","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2023050208160020300_keac557-B20","doi-asserted-by":"crossref","first-page":"276","DOI":"10.11613\/BM.2012.031","article-title":"Lessons in biostatistics interrater reliability: the kappa statistic","volume":"22","author":"McHugh","year":"2012","journal-title":"Biochem Med"},{"key":"2023050208160020300_keac557-B21","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S2213-2600(20)30168-5","article-title":"Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner Society","volume":"8","author":"Hatabu","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2023050208160020300_keac557-B22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1148\/radiol.2021204367","article-title":"Interstitial lung abnormalities: state of the art","volume":"301","author":"Hata","year":"2021","journal-title":"Radiology"},{"key":"2023050208160020300_keac557-B23","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/0895-4356(90)90159-M","article-title":"High agreement but low kappa","volume":"43","author":"Cicchetti","year":"1990","journal-title":"J Clin Epidemiol"},{"key":"2023050208160020300_keac557-B24","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","article-title":"Nintedanib in progressive fibrosing interstitial lung diseases","volume":"381","author":"Flaherty","year":"2019","journal-title":"N Engl J Med"},{"key":"2023050208160020300_keac557-B25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/ard.62.2.97","article-title":"Predictors of end stage lung disease in systemic sclerosis","volume":"62","author":"Steen","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"2023050208160020300_keac557-B26","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/art.1780370903","article-title":"Severe restrictive lung disease in systemic sclerosis","volume":"37","author":"Steen","year":"1994","journal-title":"Arthritis Rheum"},{"key":"2023050208160020300_keac557-B27","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/art.40130","article-title":"Short-term pulmonary function trends are predictive of mortality in interstitial lung disease associated with systemic sclerosis","volume":"69","author":"Goh","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2023050208160020300_keac557-B28","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/annrheumdis-2018-213708","article-title":"Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts","volume":"78","author":"Volkmann","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2023050208160020300_keac557-B29","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1378\/chest.13-2626","article-title":"Predictors of mortality and progression in scleroderma-associated interstitial lung disease: a systematic review","volume":"146","author":"Winstone","year":"2014","journal-title":"Chest"},{"key":"2023050208160020300_keac557-B30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/2397198319869564","article-title":"Prediction of organ involvement and survival in systemic sclerosis patients in the first 5 years from diagnosis","volume":"5","author":"van den Hombergh","year":"2020","journal-title":"J Scleroderma Relat Disord"},{"key":"2023050208160020300_keac557-B31","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1007\/s10067-020-05105-4","article-title":"Progressive lung fibrosis and mortality can occur in early systemic sclerosis patients without pulmonary abnormalities at baseline assessment","volume":"39","author":"Vanaken","year":"2020","journal-title":"Clin Rheumatol"},{"key":"2023050208160020300_keac557-B32","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/art.38390","article-title":"Prediction of pulmonary complications and long-term survival in systemic sclerosis","volume":"66","author":"Nihtyanova","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2023050208160020300_keac557-B33","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.2217\/fon-2017-0161","article-title":"The emerging role of professional social media use in oncology","volume":"13","author":"Sedrak","year":"2017","journal-title":"Future Oncol"},{"key":"2023050208160020300_keac557-B34","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s12350-019-01673-4","article-title":"Refer WiselyTM: Leveraging social media to promote interdisciplinary collaboration on the use of cardiac testing","volume":"26","author":"Winchester","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"2023050208160020300_keac557-B35","first-page":"1","article-title":"Proceedings of the American College of Rheumatology\/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: a Multidisciplinary Approach to Address Challenges and Opportunities","volume":"0","author":"Fischer","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2023050208160020300_keac557-B36","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1080\/03009742.2017.1299793","article-title":"There is a need for new systemic sclerosis subset criteria. A content analytic approach","volume":"47","author":"Johnson","year":"2018","journal-title":"Scand J Rheumatol"},{"key":"2023050208160020300_keac557-B37","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/BOR.0000000000000443","article-title":"Progress in the clinical classification of systemic sclerosis","volume":"29","author":"Johnson","year":"2017","journal-title":"Curr Opin Rheumatol"},{"key":"2023050208160020300_keac557-B38","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/BOR.0000000000000795","article-title":"Treatment for systemic sclerosis-associated interstitial lung disease","volume":"33","author":"Roofeh","year":"2021","journal-title":"Curr Opin Rheumatol"},{"key":"2023050208160020300_keac557-B39","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/art.41933","article-title":"Systemic sclerosis-associated interstitial lung disease: how to incorporate two food and drug administration-approved therapies in clinical practice","volume":"74","author":"Khanna","year":"2022","journal-title":"Arthritis Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keac557\/46536923\/keac557.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/5\/1877\/50119867\/keac557.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/5\/1877\/50119867\/keac557.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T08:19:08Z","timestamp":1683015548000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/62\/5\/1877\/6730724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,29]]},"references-count":39,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,9,29]]},"published-print":{"date-parts":[[2023,5,2]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keac557","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,5,1]]},"published":{"date-parts":[[2022,9,29]]}}}